{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T19:33:17Z","timestamp":1771788797196,"version":"3.50.1"},"reference-count":55,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1613,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1600-0714.2011.01031.x","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T12:37:52Z","timestamp":1301747872000},"page":"706-714","source":"Crossref","is-referenced-by-count":44,"title":["Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival"],"prefix":"10.1111","volume":"40","author":[{"given":"Stamatios","family":"Theocharis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Giaginis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Jouffroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelique","family":"Girod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Sastre-Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,2]]},"reference":[{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0300-9084(01)01347-5","article-title":"Chromatin structure and dynamics: functional implications","volume":"83","author":"Morales","year":"2001","journal-title":"Biochimie"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1074-5521(02)00092-3","article-title":"Deacetylase enzymes: biological functions and the use of small-molecule inhibitors","volume":"9","author":"Grozinger","year":"2002","journal-title":"Chem Biol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"Glozak","year":"2007","journal-title":"Oncogene"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB6|cit6","first-page":"489","article-title":"Histone deacetylase inhibitors: a novel target of anticancer therapy (review)","volume":"15","author":"Kouraklis","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2165\/11315680-000000000-00000","article-title":"Histone deacetylase inhibitors: current status and overview of recent clinical trials","volume":"69","author":"Ma","year":"2009","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1574-6976.2007.00100.x","article-title":"Histone modifications and chromatin dynamics: a focus on filamentous fungi","volume":"32","author":"Brosch","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.20022","article-title":"Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer","volume":"59","author":"Halkidou","year":"2004","journal-title":"Prostate"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1593\/neo.08474","article-title":"Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas","volume":"10","author":"Weichert","year":"2008","journal-title":"Neoplasia"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(08)70004-4","article-title":"Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis","volume":"9","author":"Weichert","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/1078-0432.CCR-07-0990","article-title":"Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo","volume":"14","author":"Weichert","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-8-381","article-title":"Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer","volume":"8","author":"Fritzsche","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB18|cit18","first-page":"1439","article-title":"Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer","volume":"21","author":"Wang","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MPA.0b013e31815f2c2a","article-title":"Expression of hypoxia-inducible factor-1a, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation","volume":"36","author":"Miyake","year":"2008","journal-title":"Pancreas"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000111106","article-title":"Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma","volume":"72","author":"Rikimaru","year":"2007","journal-title":"Oncology"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.lungcan.2004.03.021","article-title":"Histone deacetylase 1 mRNA expression in lung cancer","volume":"46","author":"Sasaki","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-004-1668-2","article-title":"Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis","volume":"90","author":"Krusche","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-005-6001-1","article-title":"Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast","volume":"94","author":"Zhang","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2559.2008.03109.x","article-title":"Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma","volume":"53","author":"Marquard","year":"2008","journal-title":"Histopathology"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2559.2009.03290.x","article-title":"Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas","volume":"54","author":"Marquard","year":"2009","journal-title":"Histopathology"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S1368-8375(01)00109-9","article-title":"Oral cavity and pharynx cancer incidence in the United States, 1975-1988","volume":"38","author":"Canto","year":"2002","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","article-title":"Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis","volume":"360","author":"Brenner","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","article-title":"Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44\u2003years","volume":"103","author":"Shiboski","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","article-title":"Metastasis of squamous cell carcinoma of the oral tongue","volume":"26","author":"Sano","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1054\/bjoc.2000.1323","article-title":"Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors","volume":"83","author":"Kantola","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjc.6604633","article-title":"Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma","volume":"99","author":"Wangsa","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hed.10094","article-title":"Prognostic factors clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score and pathologic features","volume":"24","author":"Po Wing Yen","year":"2002","journal-title":"Head Neck"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1445-2197.2008.04791.x","article-title":"Prognostic factors in the surgical treatment of patients with oral carcinoma","volume":"79","author":"Patel","year":"2009","journal-title":"ANZ J Surg"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.oraloncology.2008.08.011","article-title":"Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients","volume":"45","author":"Chang","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.phrs.2006.08.003","article-title":"NF-kappaB signaling pathway is involved in growth inhibition, G2\/M arrest and apoptosis induced by trichostatin A in human tongue carcinoma cells","volume":"54","author":"Yao","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/j.oraloncology.2009.05.563","article-title":"PTEN\/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells","volume":"45","author":"Gan","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","article-title":"Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival","volume":"29","author":"Brandwein-Gensler","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000227604","article-title":"The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue","volume":"54","author":"Shintani","year":"1997","journal-title":"Oncology"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB42|cit42","volume-title":"Pathology and genetics of head and neck tumours","author":"Barnes","year":"2005"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9610(00)00433-5","article-title":"A comparison of prognostic significance of tumor diameter, length, width, thickness area, volume and clinicopathological features of oral tongue carcinoma","volume":"180","author":"Po Wing Yen","year":"2000","journal-title":"Am J Surg"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/1097-0142(19950401)75:7<1649::AID-CNCR2820750715>3.0.CO;2-E","article-title":"Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas","volume":"75","author":"Klijanienko","year":"1995","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00432-010-0882-z","article-title":"Peroxisome proliferator-activated receptor-gamma in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival","volume":"137","author":"Theocharis","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0714.2010.00945.x","article-title":"Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival","volume":"40","author":"Theocharis","year":"2011","journal-title":"J Oral Med Pathol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.oraloncology.2010.01.009","article-title":"Potential role of HDAC inhibitors in cancer therapy: insights into oral squamous cell carcinoma","volume":"46","author":"Iglesias-Linares","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-005-5044-4","article-title":"Epidemiology of head and neck cancer: magnitude of the problem","volume":"24","author":"D\u00f6brossy","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-005-5051-5","article-title":"Progression of head and neck squamous cell cancer","volume":"24","author":"T\u00edm\u00e1r","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.joms.2005.11.094","article-title":"Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity","volume":"65","author":"Bell","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cgt.2008.81","article-title":"The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells","volume":"16","author":"Katsura","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB52|cit52","first-page":"1233","article-title":"Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells","volume":"28","author":"Sato","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB53|cit53","first-page":"1181","article-title":"Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid","volume":"30","author":"Rikiishi","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00280-009-0969-x","article-title":"Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells","volume":"64","author":"Suzuki","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.1600-0714.2011.01031.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.chembiol.2010.06.014","article-title":"Nitric oxide-mediated histone hyperacetylation in oral cancer: target for a water-soluble HAT inhibitor, CTK7A","volume":"17","author":"Arif","year":"2010","journal-title":"Chem Biol"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2011.01031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0714.2011.01031.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:12:42Z","timestamp":1625656362000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2011.01031.x"}},"subtitle":["HDACs expression in mobile tongue cancer"],"short-title":[],"issued":{"date-parts":[[2011,4,2]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2011.01031.x","relation":{},"ISSN":["0904-2512"],"issn-type":[{"value":"0904-2512","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,2]]}}}